Cargando…
Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with a high degree of immune tolerance. Galectins induce induction of immune evasion behavior in tumor cells. Galectins each play a role in promoting PDAC progression during PDAC immune evasion by coordinating...
Autores principales: | Jiang, Zhengting, Zhang, Wenjie, Sha, Gengyu, Wang, Daorong, Tang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688059/ https://www.ncbi.nlm.nih.gov/pubmed/36428567 http://dx.doi.org/10.3390/cancers14225475 |
Ejemplares similares
-
Small extracellular vesicle-mediated metabolic reprogramming: from tumors to pre-metastatic niche formation
por: Jiang, Chuwen, et al.
Publicado: (2023) -
Pancreatic Satellite Cells Derived Galectin-1 Increase the Progression and Less Survival of Pancreatic Ductal Adenocarcinoma
por: Tang, Dong, et al.
Publicado: (2014) -
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
por: Bogut, Ana, et al.
Publicado: (2023) -
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
por: Seifert, Adrian M., et al.
Publicado: (2020) -
The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)